1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Bioinformatics-as-a-Service (BaaS) Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Bioinformatics-as-a-Service (BaaS) Market, by Service Type
8.1.1. Sequence Analysis
8.1.1.1. Market Revenue and Forecast
8.1.2. Functional & Structural Analysis
8.1.2.1. Market Revenue and Forecast
8.1.3. Data Mining & Integration
8.1.3.1. Market Revenue and Forecast
8.1.4. Genome Assembly & Annotation
8.1.4.1. Market Revenue and Forecast
8.1.5. Molecular Modeling & Simulation
8.1.5.1. Market Revenue and Forecast
8.1.6. Customized Workflows
8.1.6.1. Market Revenue and Forecast
8.1.7. Data Storage & Management
8.1.7.1. Market Revenue and Forecast
8.1.8. Others
8.1.8.1. Market Revenue and Forecast
9.1. Bioinformatics-as-a-Service (BaaS) Market, by Deployment Mode
9.1.1. Cloud-Based BaaS
9.1.1.1. Market Revenue and Forecast
9.1.2. Web-Based Platforms
9.1.2.1. Market Revenue and Forecast
9.1.3. On-Premises (Managed Services)
9.1.3.1. Market Revenue and Forecast
10.1. Bioinformatics-as-a-Service (BaaS) Market, by Application
10.1.1. Genomics
10.1.1.1. Market Revenue and Forecast
10.1.2. Transcriptomics
10.1.2.1. Market Revenue and Forecast
10.1.3. Proteomics
10.1.3.1. Market Revenue and Forecast
10.1.4. Metabolomics
10.1.4.1. Market Revenue and Forecast
10.1.5. Drug Discovery & Development
10.1.5.1. Market Revenue and Forecast
10.1.6. Clinical Diagnostics
10.1.6.1. Market Revenue and Forecast
10.1.7. Agricultural & Environmental Research
10.1.7.1. Market Revenue and Forecast
10.1.8. Others
10.1.8.1. Market Revenue and Forecast
11.1. Bioinformatics-as-a-Service (BaaS) Market, by End User
11.1.1. Pharmaceutical & Biotechnology Companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Academic & Research Institutes
11.1.2.1. Market Revenue and Forecast
11.1.3. Clinical & Diagnostic Laboratories
11.1.3.1. Market Revenue and Forecast
11.1.4. Contract Research Organizations (CRO)
11.1.4.1. Market Revenue and Forecast
11.1.5. Hospitals & Healthcare Providers
11.1.5.1. Market Revenue and Forecast
11.1.6. Agricultural & Environmental Organizations
11.1.6.1. Market Revenue and Forecast
12.1. Bioinformatics-as-a-Service (BaaS) Market, by Pricing Model
12.1.1. Subscription-Based
12.1.1.1. Market Revenue and Forecast
12.1.2. Pay-Per-Use
12.1.2.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Service Type
13.1.2. Market Revenue and Forecast, by Deployment Mode
13.1.3. Market Revenue and Forecast, by Application
13.1.4. Market Revenue and Forecast, by End User
13.1.5. Market Revenue and Forecast, by Pricing Model
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Service Type
13.1.6.2. Market Revenue and Forecast, by Deployment Mode
13.1.6.3. Market Revenue and Forecast, by Application
13.1.6.4. Market Revenue and Forecast, by End User
13.1.6.5. Market Revenue and Forecast, by Pricing Model
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Service Type
13.1.7.2. Market Revenue and Forecast, by Deployment Mode
13.1.7.3. Market Revenue and Forecast, by Application
13.1.7.4. Market Revenue and Forecast, by End User
13.1.7.5. Market Revenue and Forecast, by Pricing Model
13.2. Europe
13.2.1. Market Revenue and Forecast, by Service Type
13.2.2. Market Revenue and Forecast, by Deployment Mode
13.2.3. Market Revenue and Forecast, by Application
13.2.4. Market Revenue and Forecast, by End User
13.2.5. Market Revenue and Forecast, by Pricing Model
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Service Type
13.2.6.2. Market Revenue and Forecast, by Deployment Mode
13.2.6.3. Market Revenue and Forecast, by Application
13.2.7. Market Revenue and Forecast, by End User
13.2.8. Market Revenue and Forecast, by Pricing Model
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Service Type
13.2.9.2. Market Revenue and Forecast, by Deployment Mode
13.2.9.3. Market Revenue and Forecast, by Application
13.2.10. Market Revenue and Forecast, by End User
13.2.11. Market Revenue and Forecast, by Pricing Model
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Service Type
13.2.12.2. Market Revenue and Forecast, by Deployment Mode
13.2.12.3. Market Revenue and Forecast, by Application
13.2.12.4. Market Revenue and Forecast, by End User
13.2.13. Market Revenue and Forecast, by Pricing Model
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Service Type
13.2.14.2. Market Revenue and Forecast, by Deployment Mode
13.2.14.3. Market Revenue and Forecast, by Application
13.2.14.4. Market Revenue and Forecast, by End User
13.2.15. Market Revenue and Forecast, by Pricing Model
13.3. APAC
13.3.1. Market Revenue and Forecast, by Service Type
13.3.2. Market Revenue and Forecast, by Deployment Mode
13.3.3. Market Revenue and Forecast, by Application
13.3.4. Market Revenue and Forecast, by End User
13.3.5. Market Revenue and Forecast, by Pricing Model
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Service Type
13.3.6.2. Market Revenue and Forecast, by Deployment Mode
13.3.6.3. Market Revenue and Forecast, by Application
13.3.6.4. Market Revenue and Forecast, by End User
13.3.7. Market Revenue and Forecast, by Pricing Model
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Service Type
13.3.8.2. Market Revenue and Forecast, by Deployment Mode
13.3.8.3. Market Revenue and Forecast, by Application
13.3.8.4. Market Revenue and Forecast, by End User
13.3.9. Market Revenue and Forecast, by Pricing Model
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Service Type
13.3.10.2. Market Revenue and Forecast, by Deployment Mode
13.3.10.3. Market Revenue and Forecast, by Application
13.3.10.4. Market Revenue and Forecast, by End User
13.3.10.5. Market Revenue and Forecast, by Pricing Model
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Service Type
13.3.11.2. Market Revenue and Forecast, by Deployment Mode
13.3.11.3. Market Revenue and Forecast, by Application
13.3.11.4. Market Revenue and Forecast, by End User
13.3.11.5. Market Revenue and Forecast, by Pricing Model
13.4. MEA
13.4.1. Market Revenue and Forecast, by Service Type
13.4.2. Market Revenue and Forecast, by Deployment Mode
13.4.3. Market Revenue and Forecast, by Application
13.4.4. Market Revenue and Forecast, by End User
13.4.5. Market Revenue and Forecast, by Pricing Model
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Service Type
13.4.6.2. Market Revenue and Forecast, by Deployment Mode
13.4.6.3. Market Revenue and Forecast, by Application
13.4.6.4. Market Revenue and Forecast, by End User
13.4.7. Market Revenue and Forecast, by Pricing Model
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Service Type
13.4.8.2. Market Revenue and Forecast, by Deployment Mode
13.4.8.3. Market Revenue and Forecast, by Application
13.4.8.4. Market Revenue and Forecast, by End User
13.4.9. Market Revenue and Forecast, by Pricing Model
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Service Type
13.4.10.2. Market Revenue and Forecast, by Deployment Mode
13.4.10.3. Market Revenue and Forecast, by Application
13.4.10.4. Market Revenue and Forecast, by End User
13.4.10.5. Market Revenue and Forecast, by Pricing Model
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Service Type
13.4.11.2. Market Revenue and Forecast, by Deployment Mode
13.4.11.3. Market Revenue and Forecast, by Application
13.4.11.4. Market Revenue and Forecast, by End User
13.4.11.5. Market Revenue and Forecast, by Pricing Model
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Service Type
13.5.2. Market Revenue and Forecast, by Deployment Mode
13.5.3. Market Revenue and Forecast, by Application
13.5.4. Market Revenue and Forecast, by End User
13.5.5. Market Revenue and Forecast, by Pricing Model
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Service Type
13.5.6.2. Market Revenue and Forecast, by Deployment Mode
13.5.6.3. Market Revenue and Forecast, by Application
13.5.6.4. Market Revenue and Forecast, by End User
13.5.7. Market Revenue and Forecast, by Pricing Model
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Service Type
13.5.8.2. Market Revenue and Forecast, by Deployment Mode
13.5.8.3. Market Revenue and Forecast, by Application
13.5.8.4. Market Revenue and Forecast, by End User
13.5.8.5. Market Revenue and Forecast, by Pricing Model
14.1. Illumina, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Thermo Fisher Scientific
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Qiagen N.V.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Agilent Technologies
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Fios Genomics
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Seven Bridges Genomics
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. DNAnexus
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Eagle Genomics
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Genestack
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Partek Incorporated
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client